Severe myelotoxicity in a combination of gefitinib and vinorelbine.
Yoshimura
Mana
M
Nakamura
Shinichiro
S
Imamura
Fumio
F
Ueno
Kiyonobu
K
Yamamoto
Suguru
S
Igarashi
Tsuyoshi
T
D000368:Aged; D000740:Anemia / Q000139:chemically induced*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D005260:Female; D000077156:Gefitinib; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced*; D010865:Pilot Projects; D011799:Quinazolines / Q000008:administration & dosage / Q000009:adverse effects; D013921:Thrombocytopenia / Q000139:chemically induced*; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
D011799:Quinazolines; D014747:Vinblastine; D000077235:Vinorelbine; D000077156:Gefitinib